Bond Market Signals Concern That Fed May Be Behind on Inflation as Warsh Assumes Leadership SpaceX IPO Could Be the Largest in History Infographic Suggests Prediction Market Signals Potential US Government Stakes in IonQ Micron and Anduril Navigating Record Gas Prices Effective Strategies to Reduce Fuel Costs BHP Emissions Reduction Efforts Stall as WA Premier Urges Decarbonisation Tax Season 2025 New Wrinkles for Online Sellers and EV Owners May Offer Savings BNR Q3 2022 Earnings EPS Surpasses Estimates Amid Operational Challenges Byline Bancorp Inc BY Q1 2026 Earnings EPS Beats Estimates by 755 as Stock Edges Lower AVD Q3 2025 Earnings Massive EPS Miss Sends Stock Lower ALHC Q1 2026 Earnings Strong Earnings Beat Signals Operational Progress Mesoblast Q1 2026 Earnings Narrower Loss Surprises on Cost Discipline Stock Gains ADAMM Q1 2026 Earnings Strong EPS Beat Driven by Investment Income SmartFinancial Inc SMBK Edges Higher as Support Holds Resistance Looms at 4359 Duff Phelps Utility and Infrastructure Fund DPG Edges Higher Amid Steady Utility Sector Performance Starry Sea Acquisition Corp Rights SSEAR Holds Steady at 017 Amid Thin Trading TFS Financial Corporation TFSL Edges Higher Key Levels in Focus After Modest Gain Home Depot HD Slips Slightly as Support Levels Hold Near 295 Trumps Beijing Visit Absence of Disaster Seen as Modest Progress for USChina Trade Relations JANX Q1 2026 Earnings NarrowerthanExpected Loss Buoys Biotech Sentiment Workiva WK Edges Lower Amid Sector Pressure Key Levels in Focus Veris Residential Inc VRE Q4 2025 Earnings Narrowing Losses and a Slight Market Uptick Immunome Inc IMNM Q1 2026 Earnings NarrowerThanExpected Loss Highlights Operational Discipline Amid Pipeline Progress CELC Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress but Stock Slips iQIYI Q1 2026 Earnings EPS Misses Estimates as Profitability Challenges Persist ASTC Q1 2024 Earnings Loss per Share of 179 Reflects Continued PreRevenue Investment Phase Savara Inc SVRA Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Biotech Advances Pipeline Mineralys Therapeutics MLYS Q1 2026 Earnings Narrowerthanexpected Loss as Clinical Progress Continues